Lee

Lee

Auto-generated profile, based on publicly available information

Lee

Division of Bioscience and Bioinformatics, Myongji University, Myongji-ro 116, Cheoin-gu, Yongin, 17058, Gyeonggi-do, Republic of Korea.

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2004 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
UMUk Yeol Moon
Uk Yeol Moon
SPSu Jin Park
Su Jin Park
SOSang Taek Oh
Sang Taek Oh
WKWan-Uk Kim
Wan-Uk Kim
SPSung-Hwan Park
Sung-Hwan Park
SLSuk Kyeong Lee
Suk Kyeong Lee
Various genetic and environmental factors appear to be involved in systemic lupus erythematosus (SLE). Epstein–Barr virus (EBV) is among the environmental factors that are suspected of predisposing to SLE, based on the characteristics of EBV itself and on sequence homologies between autoantigens and EBV antigens. In addition, higher titers of anti-EBV antibodies and increased EBV seroconversion rates have been observed in SLE patients as compared with healthy control individuals. Serologic responses do not directly reflect EBV status within the body. Clarification of the precise status of EBV infection in SLE patients would help to improve our understanding of the role played by EBV in this disease. In the present study we determined EBV types in SLE patients (n = 66) and normal control individual (n = 63) by direct PCR analysis of mouthwash samples. We also compared EBV load in blood between SLE patients (n = 24) and healthy control individuals (n = 29) using semiquantitative PCR assay. The number of infections and EBV type distribution were similar between adult SLE patients and healthy control individuals (98.5% versus 94%). Interestingly, the EBV burden in peripheral blood mononuclear cells (PBMCs) was over 15-fold greater in SLE patients than in healthy control individuals (mean ± standard deviation: 463 ± 570 EBV genome copies/3 μg PBMC DNA versus 30 ± 29 EBV genome copies/3 μg PBMC DNA; P = 0.001), suggesting that EBV infection is abnormally regulated in SLE. The abnormally increased proportion of EBV-infected B cells in the SLE patients may contribute to enhanced autoantibody production in this disease.

12 December 2012 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HLHuaiwei Liu
Huaiwei Liu
KRKristine Rose M. Ramos
Kristine Rose M. Ramos
KVKris Niño G. Valdehuesa
Kris Niño G. Valdehuesa
Grace M. NisolaGrace M. Nisola
Grace M. Nisola
WLWon-Keun Lee
Won-Keun Lee
WCWook-Jin Chung
Wook-Jin Chung

1 September 2011 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
SHSeung-Woo Hong
Seung-Woo Hong
JSJae-Sik Shin
Jae-Sik Shin
YLYoung-Min Lee
Young-Min Lee
DKDong-Gil Kim
Dong-Gil Kim
SLSok-Young Lee
Sok-Young Lee
WLWon-Keun Lee
Won-Keun Lee
Apoptosis signal-regulating kinase 1 (ASK1) is a key factor for controlling several cellular events including the cell cycle, senescence and apoptosis, in response to reactive oxygen species (ROS)....

9 February 2021 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
ABAngelo Bañares
Angelo Bañares
Grace M. NisolaGrace M. Nisola
Grace M. Nisola
KVKris N. G. Valdehuesa
Kris N. G. Valdehuesa
WLWon-Keun Lee
Won-Keun Lee
WCWook-Jin Chung
Wook-Jin Chung
The lignocellulosic sugar d-xylose has recently gained prominence as an inexpensive alternative substrate for the production of value-added compounds using genetically modified organisms. Among the prokaryotes, Escherichia coli has become the de facto host for the development of engineered microbial cell factories. The favored status of E. coli resulted from a century of scientific explorations leading to a deep understanding of its systems. However, there are limited literature reviews that discuss engineered E. coli as a platform for the conversion of d-xylose to any target compounds. Additionally, available critical review articles tend to focus on products rather than the host itself. This review aims to provide relevant and current information about significant advances in the metabolic engineering of d-xylose metabolism in E. coli. This focusses on unconventional and synthetic d-xylose metabolic pathways as several review articles have already discussed the engineering of native d-xylose metabolism. This paper, in particular, is essential to those who are working on engineering of d-xylose metabolism using E. coli as the host.


1 September 2016 in Toxicology Letters
Verified
Journal Article
Closed access
EGEun-Yeung Gong
Eun-Yeung Gong
YSYu Jin Shin
Yu Jin Shin
IHIh-Yeon Hwang
Ih-Yeon Hwang
JKJeong Hee Kim
Jeong Hee Kim
SKSeung-Mi Kim
Seung-Mi Kim
WLWang-Jae Lee
Wang-Jae Lee